Mohammad S. Ma'koseh

Amman, AM 11941, Jordan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 42 publications

Optimizing Timing of Peripheral Blood Stem Cell Collection: A Comparative Study of Day-4 Versus Day-5 Post-G-CSF Mobilization in Healthy Allogeneic Donors.

Optimizing Timing of Peripheral Blood Stem Cell Collection: A Comparative Study of Day-4 Versus Day-5 Post-G-CSF Mobilization in Healthy Allogeneic Donors.

Journal: Biomedicines

Published: June 12, 2026

Prevalence of PD-L1 Expression in Non-Small Cell Lung Cancer: A Real-World Analysis From Jordan.

Prevalence of PD-L1 Expression in Non-Small Cell Lung Cancer: A Real-World Analysis From Jordan.

Journal: JCO global oncology

Published: May 29, 2026

Predictors of acute kidney injury following the first cycle of high-dose methotrexate in patients with hematological malignancies.

Predictors of acute kidney injury following the first cycle of high-dose methotrexate in patients with hematological malignancies.

Journal: Leukemia & lymphoma

Published: May 05, 2026

Survival and prognostic features of early-stage diffuse large B-cell lymphoma in older adults.

Survival and prognostic features of early-stage diffuse large B-cell lymphoma in older adults.

Journal: Hematology (Amsterdam, Netherlands)

Published: April 01, 2026

Outcomes of Hematopoietic Cell Transplantation With Post-Transplant Cyclophosphamide-Based GVHD Prophylaxis in Acute Myeloid Leukemia and Myelodysplastic Syndromes Patients Over 70 Years of Age: A Comparative Analysis by Age Group.

Outcomes of Hematopoietic Cell Transplantation With Post-Transplant Cyclophosphamide-Based GVHD Prophylaxis in Acute Myeloid Leukemia and Myelodysplastic Syndromes Patients Over 70 Years of Age: A Comparative Analysis by Age Group.

Journal: Clinical lymphoma, myeloma & leukemia

Published: March 25, 2026

Outcomes of allogeneic hematopoietic cell transplantation in patients with carbapenem-resistant organisms infection: a propensity score-matched analysis.

Outcomes of allogeneic hematopoietic cell transplantation in patients with carbapenem-resistant organisms infection: a propensity score-matched analysis.

Journal: Frontiers in transplantation

Published: February 26, 2026

Evolution of outcomes in autologous stem cell transplantation for hodgkin lymphoma over 2 decades at King Hussein cancer center.

Evolution of outcomes in autologous stem cell transplantation for hodgkin lymphoma over 2 decades at King Hussein cancer center.

Journal: Annals of hematology

Published: November 17, 2025

Tailoring Intensity: A Perspective on Thiotepa, Busulfan, and Fludarabine (TBF) Conditioning for Acute Leukemias and Myeloproliferative Neoplasms.

Tailoring Intensity: A Perspective on Thiotepa, Busulfan, and Fludarabine (TBF) Conditioning for Acute Leukemias and Myeloproliferative Neoplasms.

Journal: Transplantation and cellular therapy

Published: October 01, 2025

Comparative Evaluation of Risk Assessment Models for Predicting Venous Thromboembolic Events in Cancer Patients with Implanted Central Venous Access Devices.

Comparative Evaluation of Risk Assessment Models for Predicting Venous Thromboembolic Events in Cancer Patients with Implanted Central Venous Access Devices.

Journal: Cancers

Published: August 28, 2025

Dose adjusted EPOCH-R is superior to RCHOP in frontline treatment of mediastinal large B cell lymphoma.

Dose adjusted EPOCH-R is superior to RCHOP in frontline treatment of mediastinal large B cell lymphoma.

Journal: Hematology (Amsterdam, Netherlands)

Published: June 18, 2025

Complex immunotherapy-mediated response patterns depicted on serial 18F-FDG PET imaging of Hodgkin lymphoma patient undergoing pembrolizumab therapy.

Complex immunotherapy-mediated response patterns depicted on serial 18F-FDG PET imaging of Hodgkin lymphoma patient undergoing pembrolizumab therapy.

Journal: Asia Oceania journal of nuclear medicine & biology

Published: March 19, 2025

Therapy-related Myeloid Neoplasms After Autologous Stem Cell Transplantation for Lymphoma: A Single-Center Experience.

Therapy-related Myeloid Neoplasms After Autologous Stem Cell Transplantation for Lymphoma: A Single-Center Experience.

Journal: Blood cell therapy

Published: March 10, 2025

Showing 1-12 of 42

Last Updated: 09/26/2026